Cargando…

PPARδ Activation Acts Cooperatively with 3-Phosphoinositide-Dependent Protein Kinase-1 to Enhance Mammary Tumorigenesis

Peroxisome proliferator-activated receptorδ (PPARδ) is a transcription factor that is associated with metabolic gene regulation and inflammation. It has been implicated in tumor promotion and in the regulation of 3-phosphoinositide-dependent kinase-1 (PDK1). PDK1 is a key regulator of the AGC protei...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pollock, Claire B., Yin, Yuzhi, Yuan, Hongyan, Zeng, Xiao, King, Sruthi, Li, Xin, Kopelovich, Levy, Albanese, Chris, Glazer, Robert I.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3020974/ https://www.ncbi.nlm.nih.gov/pubmed/21297860 http://dx.doi.org/10.1371/journal.pone.0016215

Ejemplares similares

PPARγ and PPARδ as Modulators of Neoplasia and Cell Fate
por: Glazer, Robert I., et al.
Publicado: (2008)

Induction of Metastatic Gastric Cancer by Peroxisome Proliferator-Activated Receptorδ Activation
por: Pollock, Claire B., et al.
Publicado: (2010)

PPARδ as a Metabolic Initiator of Mammary Neoplasia and Immune Tolerance
por: Glazer, Robert I.
Publicado: (2016)

PPARs as determinants of the estrogen receptor lineage: use of synthetic lethality for the treatment of estrogen receptor-negative breast cancer
por: Glazer, Robert I., et al.
Publicado: (2017)

3-Phosphoinositide-dependent Protein Kinase-1 (PDK1) promotes invasion and activation of matrix metalloproteinases
por: Xie, Zhihui, et al.
Publicado: (2006)

Drug-Targeted Inhibition of Peroxisome Proliferator-Activated Receptorγ Enhances the Chemopreventive Effect of Anti-Estrogen
por: Yuan, Hongyan, et al.
Publicado: (2012)

Erratum: Drug-Targeted Inhibition of Peroxisome Proliferator-Activated Receptor-gamma Enhances the Chemopreventive Effect of Anti-Estrogen Therapy
por: Yuan, Hongyan, et al.
Publicado: (2018)

A Role for PPARβ/δ in Tumor Stroma and Tumorigenesis
por: Müller, Rolf, et al.
Publicado: (2008)

Disease Evolution and Response to Rapamycin in Activated Phosphoinositide 3-Kinase δ Syndrome: The European Society for Immunodeficiencies-Activated Phosphoinositide 3-Kinase δ Syndrome Registry
por: Maccari, Maria Elena, et al.
Publicado: (2018)

Structural, Biochemical, and Biophysical Characterization of Idelalisib Binding to Phosphoinositide 3-Kinase δ
por: Somoza, John R., et al.
Publicado: (2015)

Deconvolution of bulk RNA sequencing in activated phosphoinositide 3‐kinase δ syndrome
por: Huang, Xia, et al.
Publicado: (2023)

Inhibition of Doxorubicin-Induced Senescence by PPARδ Activation Agonists in Cardiac Muscle Cells: Cooperation between PPARδ and Bcl6
por: Altieri, Paola, et al.
Publicado: (2012)

Occurrence of B-cell lymphomas in patients with Activated Phosphoinositide 3-Kinase δ syndrome
por: Kracker, Sven, et al.
Publicado: (2014)

Distinct roles for phosphoinositide 3-kinases γ and δ in malignant B cell migration
por: Ali, Ahmed Y., et al.
Publicado: (2018)

Phosphoinositide 3-kinase δ regulates membrane fission of Golgi carriers for selective cytokine secretion
por: Low, Pei Ching, et al.
Publicado: (2010)

Case Report: First Occurrence of Plasmablastic Lymphoma in Activated Phosphoinositide 3-Kinase δ Syndrome
por: Yin, Zexi, et al.
Publicado: (2021)

The transcription factor ATF3 acts as an oncogene in mouse mammary tumorigenesis
por: Wang, Aijin, et al.
Publicado: (2008)

The protein kinase Pak4 disrupts mammary acinar architecture and promotes mammary tumorigenesis
por: Liu, Yingying, et al.
Publicado: (2010)

Plac1 Is a Key Regulator of the Inflammatory Response and Immune Tolerance In Mammary Tumorigenesis
por: Yuan, Hongyan, et al.
Publicado: (2018)

Deficiency of p110δ Isoform of the Phosphoinositide 3 Kinase Leads to Enhanced Resistance to Leishmania donovani
por: Khadem, Forough, et al.
Publicado: (2014)

Genetic Defects in Phosphoinositide 3-Kinase δ Influence CD8(+) T Cell Survival, Differentiation, and Function
por: Cannons, Jennifer L., et al.
Publicado: (2018)

Airway epithelial phosphoinositide 3-kinase-δ contributes to the modulation of fungi-induced innate immune response
por: Jeong, Jae Seok, et al.
Publicado: (2018)

Cryptotanshinone Reverses Corticosteroid Insensitivity by Inhibition of Phosphoinositide-3-Kinase-δ in Chronic Obstructive Pulmonary Disease
por: Xie, Tao, et al.
Publicado: (2023)

Two cases of successful sirolimus treatment for patients with activated phosphoinositide 3-kinase δ syndrome 1
por: Jiang, Lu, et al.
Publicado: (2023)

NO-Donating NSAIDs, PPARδ, and Cancer: Does PPARδ Contribute to Colon Carcinogenesis?
por: Mackenzie, Gerardo G., et al.
Publicado: (2008)

PPAR-δ in Vascular Pathophysiology
por: Wang, Nanping
Publicado: (2008)

Genetic or Pharmaceutical Blockade of Phosphoinositide 3-Kinase P110δ Prevents Chronic Rejection of Heart Allografts
por: Ying, Huijun, et al.
Publicado: (2012)

Phosphoinositide 3-kinase-δ regulates fungus-induced allergic lung inflammation through endoplasmic reticulum stress
por: Lee, Kyung Sun, et al.
Publicado: (2016)

Clinical spectrum and features of activated phosphoinositide 3-kinase δ syndrome: A large patient cohort study
por: Coulter, Tanya I., et al.
Publicado: (2017)

Protein Kinase C Beta in the Tumor Microenvironment Promotes Mammary Tumorigenesis
por: Wallace, Julie A., et al.
Publicado: (2014)

Conditional Expression of Human PPARδ and a Dominant Negative Variant of hPPARδ In Vivo
por: Higgins, Larry G., et al.
Publicado: (2012)

Inhibitors of phosphoinositide 3-kinase (PI3K) and phosphoinositide 3-kinase-related protein kinase family (PIKK)
por: Huang, Xueqin, et al.
Publicado: (2023)

Repeated lipopolysaccharide exposure causes corticosteroid insensitive airway inflammation via activation of phosphoinositide-3-kinase δ pathway
por: Ueda, Keitaro, et al.
Publicado: (2016)

Activated phosphoinositide 3-kinase δ syndrome associated with nephromegaly, growth hormone deficiency, bronchiectasis: a case report
por: Craig, Megan, et al.
Publicado: (2022)

Inhibition of phosphoinositide‑3 kinases γ/δ ameliorates pulmonary granuloma by rescuing Treg function in a sarcoidosis model
por: Zhang, Xian, et al.
Publicado: (2023)

Investigating the Role of PPARβ/δ in Retinal Vascular Remodeling Using Pparβ/δ-Deficient Mice
por: Ho, Sze Yuan, et al.
Publicado: (2020)

Protein tyrosine kinase 6 regulates mammary gland tumorigenesis in mouse models
por: Peng, M, et al.
Publicado: (2013)

Kinase-independent role of cyclin D1 in chromosomal instability and mammary tumorigenesis
por: Casimiro, Mathew C., et al.
Publicado: (2015)

Successful Sirolimus Treatment for Korean Patients with Activated Phosphoinositide 3-kinase δ Syndrome 1: the First Case Series in Korea
por: Kang, Ji-Man, et al.
Publicado: (2020)

NFκB-Mediated Expression of Phosphoinositide 3-Kinase δ Is Critical for Mesenchymal Transition in Retinal Pigment Epithelial Cells
por: Han, Haote, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_g3dlm3opbe81j4g9g00lb71htb